Viewing Study NCT06051851


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-01-24 @ 4:34 AM
Study NCT ID: NCT06051851
Status: RECRUITING
Last Update Posted: 2023-09-25
First Post: 2023-09-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer
Sponsor:
Organization: